Showing results (1-10 of 421) with videos related to
Sort By:
Pageof 43
Clinical Lymphoma & Myeloma|April 14, 2009
Targeting CD40 in Waldenström's macroglobulinemiaMark Lee, Ranjana AdvaniExpert Review of Anticancer Therapy|September 15, 2010
Risk stratification in extranodal natural killer/T-cell lymphomaHolbrook Kohrt, Mark Lee, Ranjana AdvaniHematology. American Society of Hematology. Education Program|December 14, 2011
Optimal therapy of advanced Hodgkin lymphomaRanjana AdvaniLeukemia & Lymphoma|November 4, 2009
Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatmentHolbrook Kohrt, Ranjana AdvaniJournal of the National Comprehensive Cancer Network : JNCCN|August 16, 2013
Targeted therapy in relapsed classical hodgkin lymphomaShira Dinner, Ranjana AdvaniCritical Reviews in Oncology/Hematology|June 6, 2006
Treatment of mantle cell lymphoma: current approach and future directionsJoshua Brody, Ranjana AdvaniHematology/Oncology Clinics of North America|November 30, 2013
Customized targeted therapy in Hodgkin lymphoma: hype or hope?Catherine Diefenbach, Ranjana AdvaniHematology. American Society of Hematology. Education Program|December 7, 2024
When should we use it? The role of brentuximab vedotin in 2024Joseph G Schroers-Martin, Ranjana AdvaniJCO Oncology Practice|September 12, 2024
Integrating Novel Agents Into the Clinical Management of Classic Hodgkin LymphomaJoseph G Schroers-Martin, Ranjana AdvaniClinical Lymphoma, Myeloma & Leukemia|June 4, 2026
Early Stage Hodgkin Lymphoma-Are We Ready for Novel Agents?Joseph G Schroers-Martin, Ranjana AdvaniPageof 43